Vera Maria Abeler

  • Senior Consultant; MD, PhD
  • +47 22 93 56 14

Download CV (in Word format)

 

Original articles

Davidson B, Kjæreng ML, Førsund M, Danielsen HE, Kristensen GB, Abeler VM (2016)
Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma
Am J Clin Pathol, 145 (4), 449-58
DOI 10.1093/ajcp/aqw030, PubMed 27149024

Nielsen B, Hveem TS, Kildal W, Abeler VM, Kristensen GB, Albregtsen F, Danielsen HE (2014)
Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas
Cytometry A, 87 (4), 315-25
DOI 10.1002/cyto.a.22601, PubMed 25483227

Micci F, Haugom L, Abeler VM, Davidson B, Tropé CG, Heim S (2014)
Genomic profile of ovarian carcinomas
BMC Cancer, 14, 315
DOI 10.1186/1471-2407-14-315, PubMed 24886194

Davidson B, Abeler VM, Førsund M, Holth A, Yang Y, Kobayashi Y, Chen L, Kristensen GB, Shih IeM, Wang TL (2013)
Gene expression signatures of primary and metastatic uterine leiomyosarcoma
Hum Pathol, 45 (4), 691-700
DOI 10.1016/j.humpath.2013.11.003, PubMed 24485798

Micci F, Panagopoulos I, Haugom L, Dahlback HS, Pretorius ME, Davidson B, Abeler VM, Tropé CG, Danielsen HE, Heim S (2013)
Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva
Genes Chromosomes Cancer, 52 (6), 551-63
DOI 10.1002/gcc.22053, PubMed 23404381

Davidson B, Abeler VM, Hellesylt E, Holth A, Shih IeM, Skeie-Jensen T, Chen L, Yang Y, Wang TL (2012)
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma
Gynecol Oncol, 128 (2), 349-55
DOI 10.1016/j.ygyno.2012.11.021, PubMed 23178314

Frøen H, Brennhovd B, Abeler VM, Madsbu UE, Lehne G (2012)
[Young man with severe back pain]
Tidsskr Nor Laegeforen, 132 (14), 1626-9
DOI 10.4045/tidsskr.11.1059, PubMed 22875130

Pradhan M, Davidson B, Abeler VM, Danielsen HE, Tropé CG, Kristensen GB, Risberg BÅ (2012)
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
Virchows Arch, 461 (3), 291-8
DOI 10.1007/s00428-012-1275-2, PubMed 22824999

Pradhan M, Abeler VM, Danielsen HE, Sandstad B, Tropé CG, Kristensen GB, Risberg BÅ (2012)
Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
Ann Oncol, 23 (5), 1178-1184
DOI 10.1093/annonc/mdr368, PubMed 32018574

Nielsen B, Albregtsen F, Kildal W, Abeler VM, Kristensen GB, Danielsen HE (2012)
The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer
Anal Cell Pathol (Amst), 35 (4), 305-14
DOI 10.3233/ACP-2012-0065, PubMed 22596183

Kildal W, Micci F, Risberg B, Abeler VM, Kristensen GB, Heim S, Danielsen HE (2011)
Genomic imbalances in endometrial adenocarcinomas - comparison of DNA ploidy, karyotyping and comparative genomic hybridization
Mol Oncol, 6 (1), 98-107
DOI 10.1016/j.molonc.2011.10.002, PubMed 22062770

Pradhan M, Abeler VM, Danielsen HE, Sandstad B, Tropé CG, Kristensen GB, Risberg BÅ (2011)
Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
Ann Oncol, 23 (5), 1178-84
DOI 10.1093/annonc/mdr368, PubMed 21965471

Abeler VM, Nenodovic M (2011)
Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases
Int J Gynecol Pathol, 30 (3), 236-43
DOI 10.1097/PGP.0b013e318200caff, PubMed 21464730

Sert MB, Abeler V (2011)
Robot-assisted laparoscopic radical hysterectomy: comparison with total laparoscopic hysterectomy and abdominal radical hysterectomy; one surgeon's experience at the Norwegian Radium Hospital
Gynecol Oncol, 121 (3), 600-4
DOI 10.1016/j.ygyno.2011.02.002, PubMed 21353294

Micci F, Skotheim RI, Haugom L, Weimer J, Eibak AM, Abeler VM, Trope CG, Arnold N, Lothe RA, Heim S (2010)
Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes
Genes Chromosomes Cancer, 49 (11), 1046-53
DOI 10.1002/gcc.20813, PubMed 20725991

Pradhan M, Abeler VM, Davidson B, Kildal W, Nybøen A, Tropé CG, Risberg B, Danielsen HE (2010)
DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens
Int J Gynecol Pathol, 29 (6), 572-8
DOI 10.1097/PGP.0b013e3181e2e8ee, PubMed 20881853

Micci F, Haugom L, Ahlquist T, Andersen HK, Abeler VM, Davidson B, Trope CG, Lothe RA, Heim S (2010)
Genomic aberrations in borderline ovarian tumors
J Transl Med, 8, 21
DOI 10.1186/1479-5876-8-21, PubMed 20184781

Micci F, Haugom L, Ahlquist T, Abeler VM, Trope CG, Lothe RA, Heim S (2009)
Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution
J Oncol, 2010, 646340
DOI 10.1155/2010/646340, PubMed 19759843

Kildal W, Pradhan M, Abeler VM, Kristensen GB, Danielsen HE (2009)
Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters
Eur J Cancer, 45 (13), 2412-7
DOI 10.1016/j.ejca.2009.06.017, PubMed 19622417

Pradhan M, Davidson B, Tropé CG, Danielsen HE, Abeler VM, Risberg B (2009)
Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications
Virchows Arch, 454 (6), 677-83
DOI 10.1007/s00428-009-0778-y, PubMed 19421773

Kildal W, Abeler VM, Kristensen GB, Jenstad M, Thoresen SØ, Danielsen HE (2009)
The prognostic value of DNA ploidy in a total population of uterine sarcomas
Ann Oncol, 20 (6), 1037-41
DOI 10.1093/annonc/mdn765, PubMed 19201782

Micci F, Weimer J, Haugom L, Skotheim RI, Grunewald R, Abeler VM, Silins I, Lothe RA, Trope CG, Arnold N, Heim S (2009)
Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map
Genes Chromosomes Cancer, 48 (2), 184-93
DOI 10.1002/gcc.20628, PubMed 18973136

Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB (2009)
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
Histopathology, 54 (3), 355-64
DOI 10.1111/j.1365-2559.2009.03231.x, PubMed 19236512

Pretorius ME, Waehre H, Abeler VM, Davidson B, Vlatkovic L, Lothe RA, Giercksky KE, Danielsen HE (2009)
Large scale genomic instability as an additive prognostic marker in early prostate cancer
Cell Oncol, 31 (4), 251-9
DOI 10.3233/CLO-2009-0463, PubMed 19633362

Micci F, Haugom L, Abeler VM, Tropé CG, Danielsen HE, Heim S (2008)
Consistent numerical chromosome aberrations in thecofibromas of the ovary
Virchows Arch, 452 (3), 269-76
DOI 10.1007/s00428-007-0561-x, PubMed 18188592

Pradhan M, Abeler VM, Danielsen HE, Risberg B (2007)
A distinct pattern in the DNA ploidy histograms of hydatidiform moles and nonmolar abortuses is caused by accumulation of trophoblasts in the late s-phase
Int J Gynecol Pathol, 26 (4), 432-6
DOI 10.1097/pgp.0b013e31803c7c2e, PubMed 17885494

Sert B, Abeler V (2007)
Robotic radical hysterectomy in early-stage cervical carcinoma patients, comparing results with total laparoscopic radical hysterectomy cases. The future is now?
Int J Med Robot, 3 (3), 224-8
DOI 10.1002/rcs.152, PubMed 17924449

Micci F, Haugom L, Abeler VM, Bjerkehagen B, Heim S (2007)
Trisomy 7 in postoperative spindle cell nodules
Cancer Genet Cytogenet, 174 (2), 147-50
DOI 10.1016/j.cancergencyto.2006.12.003, PubMed 17452257

Hoei-Hansen CE, Kraggerud SM, Abeler VM, Kaern J, Rajpert-De Meyts E, Lothe RA (2007)
Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers
Mol Cancer, 6, 12
DOI 10.1186/1476-4598-6-12, PubMed 17274819

Lind GE, Skotheim RI, Fraga MF, Abeler VM, Esteller M, Lothe RA (2006)
Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1)
J Pathol, 210 (4), 441-9
DOI 10.1002/path.2064, PubMed 17029216

Ødegaard E, Staff AC, Abeler VM, Kopolovic J, Onsrud M, Lazarovici P, Davidson B (2006)
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma
Hum Pathol, 38 (1), 140-6
DOI 10.1016/j.humpath.2006.06.027, PubMed 16996570

Pradhan M, Abeler VM, Danielsen HE, Tropé CG, Risberg BA (2006)
Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas
Mod Pathol, 19 (9), 1227-35
DOI 10.1038/modpathol.3800641, PubMed 16729014

Sert B, Abeler VM, Dørum A, Trope CG (2006)
A new approach to treatment of early-stage cervical carcinoma: entire laparoscopic abdominal radical hysterectomy with bilateral pelvic lymphadenectomy without vaginal cuff closure--case reports
Eur J Gynaecol Oncol, 27 (5), 513-8
PubMed 17139990

Sert BM, Abeler VM (2006)
Robotic-assisted laparoscopic radical hysterectomy (Piver type III) with pelvic node dissection--case report
Eur J Gynaecol Oncol, 27 (5), 531-3
PubMed 17139995

Ødegaard E, Staff AC, Kaern J, Flørenes VA, Kopolovic J, Tropé CG, Abeler VM, Reich R, Davidson B (2005)
The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma
Gynecol Oncol, 100 (3), 462-8
DOI 10.1016/j.ygyno.2005.09.022, PubMed 16216317

Van Mieghem T, Abeler VM, Moerman P, Verbist L, Vergote I, Amant F (2005)
CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma
Gynecol Oncol, 99 (2), 493-6
DOI 10.1016/j.ygyno.2005.06.013, PubMed 16051333

Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA (2005)
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
Cancer Res, 65 (13), 5588-98
DOI 10.1158/0008-5472.CAN-05-0153, PubMed 15994931

Kildal W, Risberg B, Abeler VM, Kristensen GB, Sudbø J, Nesland JM, Danielsen HE (2005)
beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients
Eur J Cancer, 41 (8), 1127-34
DOI 10.1016/j.ejca.2005.01.022, PubMed 15911235

Lind GE, Skotheim RI, Fraga MF, Abeler VM, Henrique R, Saatcioglu F, Esteller M, Teixeira MR, Lothe RA (2005)
The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation
Mol Cancer, 4 (1), 8
DOI 10.1186/1476-4598-4-8, PubMed 15691383

Kildal W, Kaern J, Kraggerud SM, Abeler VM, Sudbø J, Tropè CG, Lothe RA, Danielsen HE (2004)
Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables
Cancer Genet Cytogenet, 155 (1), 25-32
DOI 10.1016/j.cancergencyto.2004.02.010, PubMed 15527899

Amant F, Steenkiste E, Schurmans K, Verbist L, Abeler VM, Tulunay G, de Jonge E, Massuger L, Moerman P, Vergote I (2004)
Immunohistochemical expression of CD10 antigen in uterine adenosarcoma
Int J Gynecol Cancer, 14 (6), 1118-21
DOI 10.1111/j.1048-891X.2004.14610.x, PubMed 15571618

Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-Dale AL, Helland A (2004)
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma
Hum Mutat, 24 (1), 21-34
DOI 10.1002/humu.20055, PubMed 15221786

Micci F, Teixeira MR, Haugom L, Kristensen G, Abeler VM, Heim S (2004)
Genomic aberrations in carcinomas of the uterine corpus
Genes Chromosomes Cancer, 40 (3), 229-46
DOI 10.1002/gcc.20038, PubMed 15139002

Amant F, Schurmans K, Steenkiste E, Verbist L, Abeler VM, Tulunay G, De Jonge E, Massuger L, Moerman P, Vergote I (2004)
Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma
Gynecol Oncol, 93 (3), 680-5
DOI 10.1016/j.ygyno.2004.03.021, PubMed 15196864

Luostarinen T, Lehtinen M, Bjørge T, Abeler V, Hakama M, Hallmans G, Jellum E, Koskela P, Lenner P, Lie AK, Paavonen J, Pukkala E, Saikku P, Sigstad E, Thoresen S, Youngman LD, Dillner J, Hakulinen T (2004)
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri
Eur J Cancer, 40 (7), 1058-65
DOI 10.1016/j.ejca.2003.11.032, PubMed 15093583

Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB (2004)
TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
Br J Cancer, 90 (3), 678-85
DOI 10.1038/sj.bjc.6601537, PubMed 14760384

Skotheim RI, Korkmaz KS, Klokk TI, Abeler VM, Korkmaz CG, Nesland JM, Fosså SD, Lothe RA, Saatcioglu F (2003)
NKX3.1 expression is lost in testicular germ cell tumors
Am J Pathol, 163 (6), 2149-54
DOI 10.1016/S0002-9440(10)63571-7, PubMed 14633588

Alfsen GC, Reed W, Sandstad B, Kristensen GB, Abeler VM (2003)
The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma
Cancer, 98 (9), 1880-9
DOI 10.1002/cncr.11727, PubMed 14584070

Kristensen GB, Kildal W, Abeler VM, Kaern J, Vergote I, Tropé CG, Danielsen HE (2003)
Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer
Ann Oncol, 14 (10), 1494-500
DOI 10.1093/annonc/mdg403, PubMed 14504048

Micci F, Teixeira MR, Scheistrøen M, Abeler VM, Heim S (2003)
Cytogenetic characterization of tumors of the vulva and vagina
Genes Chromosomes Cancer, 38 (2), 137-48
DOI 10.1002/gcc.10263, PubMed 12939741

Skotheim RI, Abeler VM, Nesland JM, Fosså SD, Holm R, Wagner U, Flørenes VA, Aass N, Kallioniemi OP, Lothe RA (2003)
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
Neoplasia, 5 (5), 397-404
DOI 10.1016/s1476-5586(03)80042-8, PubMed 14670177

Kildal W, Kraggerud SM, Abeler VM, Heim S, Tropé CG, Kristensen GB, Risberg B, Lothe RA, Danielsen HE (2003)
Genome profiles of bilateral dysgerminomas, a unilateral gonadoblastoma, and a metastasis from a 46, XY phenotypic female
Hum Pathol, 34 (9), 946-9
DOI 10.1016/s0046-8177(03)00345-9, PubMed 14562293

Alfsen GC, Reed W, Abeler VM (2003)
Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix
Gynecol Oncol, 90 (2), 282-9
DOI 10.1016/s0090-8258(03)00280-4, PubMed 12893188

Bjørge T, Abeler VM, Sundfør K, Tropé CG, Kaern J (2002)
Gestational trophoblastic tumors in Norway, 1968-1997: patient characteristics, treatment, and prognosis
Gynecol Oncol, 87 (1), 71-6
DOI 10.1006/gyno.2002.6801, PubMed 12468345

Sigstad E, Lie AK, Luostarinen T, Dillner J, Jellum E, Lehtinen M, Thoresen S, Abeler V (2002)
A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas
Br J Cancer, 87 (2), 175-80
DOI 10.1038/sj.bjc.6600454, PubMed 12107839

Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B, Karlsson MG (2002)
Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications
Int J Gynecol Pathol, 21 (2), 155-60
DOI 10.1097/00004347-200204000-00008, PubMed 11917225

Monclair T, Abeler VM, Kaern J, Walaas L, Zeller B, Hilstrøm C (2002)
Placental site trophoblastic tumor (PSTT) in mother and child: first report of PSTT in infancy
Med Pediatr Oncol, 38 (3), 187-91; discussion 192
DOI 10.1002/mpo.1308, PubMed 11836719

Alfsen GC, Kristensen GB, Skovlund E, Pettersen EO, Abeler VM (2001)
Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix
Cancer, 92 (9), 2471-83
DOI 10.1002/1097-0142(20011101)92:9<2471::aid-cncr1597>3.0.co;2-k, PubMed 11745305

Tropé C, Kristensen GB, Abeler VM (2001)
Clear-cell and papillary serous cancer: treatment options
Best Pract Res Clin Obstet Gynaecol, 15 (3), 433-46
DOI 10.1053/beog.2000.0187, PubMed 11476564

Dai H, Holm R, Kristensen GB, Abeler VM, Børresen-Dale AL, Helland A (2001)
Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas
Anal Cell Pathol, 23 (2), 45-9
DOI 10.1155/2001/521873, PubMed 11904459

Baekelandt M, Jorunn Nesbakken A, Kristensen GB, Tropé CG, Abeler VM (2000)
Carcinoma of the fallopian tube
Cancer, 89 (10), 2076-84
PubMed 11066048

Helland A, Kraggerud SM, Kristensen GB, Holm R, Abeler VM, Huebner K, Borresen-Dale AL, Lothe RA (2000)
Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival
Int J Cancer, 88 (2), 217-22
DOI 10.1002/1097-0215(20001015)88:2<217::aid-ijc11>3.0.co;2-i, PubMed 11004671

Alfsen GC, Thoresen SO, Kristensen GB, Skovlund E, Abeler VM (2000)
Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990
Cancer, 89 (6), 1291-9
DOI 10.1002/1097-0142(20000915)89:6<1291::AID-CNCR14>3.0.CO;2-O, PubMed 11002225

Knudsen P, Ryther AJ, Nesheim JA, Abeler VM, Nesland JM, Danielsen HE (2000)
[Telepathology at the Norwegian Radium Hospital]
Tidsskr Nor Laegeforen, 120 (18), 2170-3
PubMed 11006741

Kraggerud SM, Szymanska J, Abeler VM, Kaern J, Eknaes M, Heim S, Teixeira MR, Tropé CG, Peltomäki P, Lothe RA (2000)
DNA copy number changes in malignant ovarian germ cell tumors
Cancer Res, 60 (11), 3025-30
PubMed 10850452

Tropé C, Kaern J, Hogberg T, Abeler V, Hagen B, Kristensen G, Onsrud M, Pettersen E, Rosenberg P, Sandvei R, Sundfor K, Vergote I (2000)
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Ann Oncol, 11 (3), 281-8
DOI 10.1023/a:1008399414923, PubMed 10811493

Abeler VM, Tropé CG (2000)
[Early stage ovarian carcinoma--diagnosis and treatment]
Tidsskr Nor Laegeforen, 120 (4), 476-8
PubMed 10833940

Tropé CG, Abeler V, Baekelandt M, Kaern J (2000)
[DNA ploidy in epithelial ovarian cancer--an independent prognostic factor]
Tidsskr Nor Laegeforen, 120 (1), 43-9
PubMed 10815478

Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Müller-Holzner E, Pickartz H, Wells M (1999)
A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens
Am J Surg Pathol, 23 (9), 1102-8
DOI 10.1097/00000478-199909000-00014, PubMed 10478671

Kristensen GB, Abeler VM, Risberg B, Trop C, Bryne M (1999)
Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma
Gynecol Oncol, 74 (2), 245-51
DOI 10.1006/gyno.1999.5420, PubMed 10419739

Teixeira MR, Kristensen GB, Abeler VM, Heim S (1999)
Karyotypic findings in tumors of the vulva and vagina
Cancer Genet Cytogenet, 111 (1), 87-91
DOI 10.1016/s0165-4608(98)00226-x, PubMed 10326597

Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J, Bankfalvi A (1998)
The invasive front of carcinomas. The most important area for tumour prognosis?
Anticancer Res, 18 (6B), 4757-64
PubMed 9891553

Dørum A, Abeler VM, Heimdal K, Tropé C, Møller P (1997)
The problem of skipped generation and subclinical disease in familial breast-ovarian cancer
Acta Obstet Gynecol Scand, 76 (2), 166-8
DOI 10.3109/00016349709050074, PubMed 9049291

Skomedal H, Kristensen GB, Abeler VM, Børresen-Dale AL, Tropé C, Holm R (1997)
TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas
J Pathol, 181 (2), 158-65
DOI 10.1002/(SICI)1096-9896(199702)181:2<158::AID-PATH742>3.0.CO;2-8, PubMed 9120719

Abeler VM, Vergote IB, Kjørstad KE, Tropé CG (1996)
Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern
Cancer, 78 (8), 1740-7
DOI 10.1002/(sici)1097-0142(19961015)78:8<1740::aid-cncr14>3.0.co;2-y, PubMed 8859187

Dørum A, Kristensen GB, Abeler VM, Tropé CG, Møller P (1996)
Early detection of familial ovarian cancer
Eur J Cancer, 32A (10), 1645-51
DOI 10.1016/0959-8049(96)00137-2, PubMed 8983269

Kristensen GB, Holm R, Abeler VM, Tropé CG (1996)
Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study
Cancer, 78 (3), 433-40
DOI 10.1002/(SICI)1097-0142(19960801)78:3<433::AID-CNCR9>3.0.CO;2-K, PubMed 8697388

Kristensen GB, Karlsen F, Jenkins A, Kaern J, Abeler VM, Tropé CG (1996)
Human papilloma virus has no prognostic significance in cervical carcinoma
Eur J Cancer, 32A (8), 1349-53
DOI 10.1016/0959-8049(96)00089-5, PubMed 8869098

Kristensen GB, Holm R, Abeler VM, Tropé CG (1996)
Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study
Gynecol Oncol, 61 (3), 378-83
DOI 10.1006/gyno.1996.0160, PubMed 8641619

Scheistrøen M, Tropé C, Kaern J, Abeler VM, Pettersen EO, Kristensen GB (1996)
Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment
Gynecol Oncol, 61 (2), 253-8
DOI 10.1006/gyno.1996.0135, PubMed 8626143

Trope C, Hansen LJ, Kaern J, Abeler V (1996)
State of art in endometrial carcinoma
4TH CONGRESS OF THE EUROPEAN SOCIETY FOR GYNAECOLOGICAL ENDOSCOPY: THE UTERUS THROUGHOUT THE WOMAN'S LIFE, 107-115

Kristensen GB, Kaern J, Abeler VM, Hagmar B, Tropé CG, Pettersen EO (1995)
No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients
Gynecol Oncol, 57 (1), 79-85
DOI 10.1006/gyno.1995.1102, PubMed 7705705

Raju KS, King RJ, Kaern J, Sumner D, Abeler VM, Mandalaya S, Trope C (1995)
Influence of HSP27 and steroid receptor status on provera sensitivity, DNA-ploidy and survival of females with endometrial cancer
Int J Gynecol Cancer, 5 (2), 94-100
DOI 10.1046/j.1525-1438.1995.05020094.x, PubMed 11578461

Scheistrøen M, Tropé C, Koern J, Pettersen EO, Abeler VM, Kristensen GB (1995)
Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients
Cancer, 75 (1), 72-80
DOI 10.1002/1097-0142(19950101)75:1<72::aid-cncr2820750113>3.0.co;2-g, PubMed 7804980

Boysen M, Downs AM, Rigaut JP, Torjussen W, Högetveit AC, Andersen I, Berge SR, Solberg LA, Abeler VM, Reith A (1994)
Rates of regression and progression of dysplastic lesions in the nasal mucosa in nickel workers: a Markov model approach
Sci Total Environ, 148 (2-3), 311-8
DOI 10.1016/0048-9697(94)90409-x, PubMed 8029708

Kristiansen E, Jenkins A, Kristensen G, Ask E, Kaern J, Abeler V, Lindqvist BH, Tropé C, Kristiansen BE (1994)
Human papillomavirus infection in Norwegian women with cervical cancer
APMIS, 102 (2), 122-8
DOI 10.1111/j.1699-0463.1994.tb04856.x, PubMed 8167008

Abeler VM, Holm R, Nesland JM, Kjørstad KE (1994)
Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
Cancer, 73 (3), 672-7
DOI 10.1002/1097-0142(19940201)73:3<672::aid-cncr2820730328>3.0.co;2-r, PubMed 8299089

Kaern J, Tropé CG, Kristensen GB, Abeler VM, Pettersen EO (1993)
DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary
Int J Gynecol Cancer, 3 (6), 349-358
DOI 10.1046/j.1525-1438.1993.03060349.x, PubMed 11578368

Tropé C, Kaern J, Vergote IB, Kristensen G, Abeler V (1993)
Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors
Gynecol Oncol, 51 (2), 236-43
DOI 10.1006/gyno.1993.1279, PubMed 8276300

Reed W, Abeler VM, Tropé CG (1993)
[Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?]
Tidsskr Nor Laegeforen, 113 (20), 2569-71
PubMed 8236177

Vergote IB, Kaern J, Abeler VM, Pettersen EO, De Vos LN, Tropé CG (1993)
Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse
Am J Obstet Gynecol, 169 (1), 40-52
DOI 10.1016/0002-9378(93)90129-7, PubMed 8333474

Holm R, Abeler VM, Skomedal H, Nesland JM (1993)
Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri
Zentralbl Pathol, 139 (2), 153-6
PubMed 8103676

Kaern J, Tropé CG, Abeler VM (1993)
A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities
Cancer, 71 (5), 1810-20
DOI 10.1002/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v, PubMed 8383580

Lien HH, Blomlie V, Iversen T, Tropé C, Sundfør K, Abeler VM (1993)
Clinical stage I carcinoma of the cervix. Value of MR imaging in determining invasion into the parametrium
Acta Radiol, 34 (2), 130-2
PubMed 8452717

DOWNS AM, BOYSEN M, VOSS R, REICHBORNKJENNERUD S, ABELER V, RIGAUT JP, REITH A (1992)
HOW OFTEN IS DYSPLASIA DIAGNOSED BY BIOPSY OR SMEAR EXAMINATION - APPLICATION OF A MAXIMUM-LIKELIHOOD BASED METHOD TO THE ASSESSMENT OF DETECTION RATES IN THE NASAL-MUCOSA OF NICKEL WORKERS
Anal. Cell. Pathol., 4 (6), 451-459

Downs AM, Boysen M, Voss R, Reichborn-Kjennerud S, Abeler V, Rigaut JP, Reith A (1992)
How often is dysplasia diagnosed by biopsy or smear examination? Application of a maximum likelihood based method to the assessment of detection rates in the nasal mucosa of nickel workers
Anal Cell Pathol, 4 (6), 451-9
PubMed 1457387

Makar AP, Kristensen GB, Kaern J, Børmer OP, Abeler VM, Tropé CG (1992)
Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis
Obstet Gynecol, 79 (6), 1002-10
PubMed 1579296

Vergote IB, Vergote-De Vos LN, Abeler VM, Aas M, Lindegaard MW, Kjørstad KE, Tropé CG (1992)
Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer
Cancer, 69 (3), 741-9
DOI 10.1002/1097-0142(19920201)69:3<741::aid-cncr2820690322>3.0.co;2-g, PubMed 1730124

Abeler VM, Kjørstad KE (1992)
Endometrial adenocarcinoma with squamous cell differentiation
Cancer, 69 (2), 488-95
DOI 10.1002/1097-0142(19920115)69:2<488::aid-cncr2820690236>3.0.co;2-o, PubMed 1728379

Abeler VM, Kjørstad KE, Berle E (1992)
Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population
Int J Gynecol Cancer, 2 (1), 9-22
DOI 10.1046/j.1525-1438.1992.02010009.x, PubMed 11576230

Vergote IB, Abeler VM, Børmer OP, Stigbrand T, Tropé C, Nustad K (1992)
CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma
Tumour Biol, 13 (3), 168-74
DOI 10.1159/000217761, PubMed 1626181

Taxt T, Lundervold A, Fuglaas B, Lien H, Abeler V (1992)
Multispectral analysis of uterine corpus tumors in magnetic resonance imaging
Magn Reson Med, 23 (1), 55-76
DOI 10.1002/mrm.1910230108, PubMed 1734184

Lien HH, Blomlie V, Tropé C, Kaern J, Abeler VM (1991)
Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium
AJR Am J Roentgenol, 157 (6), 1221-3
DOI 10.2214/ajr.157.6.1950869, PubMed 1950869

Abeler VM, Kjørstad KE, Nesland JM (1991)
Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases
Cancer, 68 (1), 98-105
DOI 10.1002/1097-0142(19910701)68:1<98::aid-cncr2820680120>3.0.co;2-r, PubMed 2049761

Abeler VM, Kjørstad KE (1991)
Endometrial adenocarcinoma in Norway. A study of a total population
Cancer, 67 (12), 3093-103
DOI 10.1002/1097-0142(19910615)67:12<3093::aid-cncr2820671226>3.0.co;2-l, PubMed 2044053

Lien HH, Blomlie V, Kjørstad K, Abeler V, Kaalhus O (1991)
Clinical stage I carcinoma of the cervix: value of MR imaging in determining degree of invasiveness
AJR Am J Roentgenol, 156 (6), 1191-4
DOI 10.2214/ajr.156.6.2028866, PubMed 2028866

Sebbelov AM, Kjørstad KE, Abeler VM, Norrild B (1991)
The prevalence of human papillomavirus type 16 and 18 DNA in cervical cancer in different age groups: a study on the incidental cases of cervical cancer in Norway in 1983
Gynecol Oncol, 41 (2), 141-8
DOI 10.1016/0090-8258(91)90274-9, PubMed 1646757

RAJU KS, KJORSTAD KE, ABELER V (1991)
PROGNOSTIC FACTORS IN THE TREATMENT OF STAGE-1B ADENOCARCINOMA OF THE CERVIX
Int. J. Gynecol. Cancer, 1 (2), 69-74

Abeler VM, Kjørstad KE (1991)
Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases
Gynecol Oncol, 40 (3), 207-17
DOI 10.1016/0090-8258(90)90279-t, PubMed 2013441

Abeler VM, Kjørstad KE (1990)
Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases
Gynecol Oncol, 39 (3), 266-71
DOI 10.1016/0090-8258(90)90250-o, PubMed 2258069

Kaern J, Tropé C, Kjørstad KE, Nordal R, Sundfør K, Vergote I, Vossli S, Abeler V, Sandvei R (1990)
[A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer]
Tidsskr Nor Laegeforen, 110 (21), 2759-62
PubMed 2219049

Vergote IB, Abeler VM, Kjørstad KE, Tropé C (1990)
Management of malignant ovarian immature teratoma. Role of adriamycin
Cancer, 66 (5), 882-6
DOI 10.1002/1097-0142(19900901)66:5<882::aid-cncr2820660512>3.0.co;2-8, PubMed 2201432

Kaern J, Trope C, Kjorstad KE, Abeler V, Pettersen EO (1990)
Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary
Gynecol Oncol, 38 (3), 452-7
DOI 10.1016/0090-8258(90)90090-8, PubMed 2172121

Boysen M, Zadig E, Digernes V, Abeler V, Reith A (1990)
Nasal mucosa in workers exposed to formaldehyde: a pilot study
Br J Ind Med, 47 (2), 116-21
DOI 10.1136/oem.47.2.116, PubMed 2310715

Kaern J, Tropé C, Abeler V, Iversen T, Kjørstad K (1990)
A phase II study of 5-fluorouracil/cisplatinum in recurrent cervical cancer
Acta Oncol, 29 (1), 25-8
DOI 10.3109/02841869009089987, PubMed 2310600

Tveit KM, Kaern J, Hoifodt HK, Pettersen EO, Abeler V, Davy M, Hannisdal E, Trope C (1989)
Colony-forming ability of human ovarian carcinomas in the Courtenay soft agar assay
Anticancer Res, 9 (6), 1577-82
PubMed 2483300

Vergote I, Kjørstad K, Abeler V, Kolstad P (1989)
A randomized trial of adjuvant progestagen in early endometrial cancer
Cancer, 64 (5), 1011-6
DOI 10.1002/1097-0142(19890901)64:5<1011::aid-cncr2820640507>3.0.co;2-7, PubMed 2667746

Kjørstad KE, Bergstrøm J, Abeler V (1989)
[Clear cell adenocarcinoma of the cervix uteri and vagina in young women in Norway]
Tidsskr Nor Laegeforen, 109 (15), 1634-7
PubMed 2741143

Aukrust P, Abeler V (1989)
[Intestinal spirochaetosis]
Tidsskr Nor Laegeforen, 109 (6), 698-9
PubMed 2922737

Stalsberg H, Abeler V, Blom GP, Bostad L, Skarland E, Westgaard G (1988)
Observer variation in histologic classification of malignant and borderline ovarian tumors
Hum Pathol, 19 (9), 1030-5
DOI 10.1016/s0046-8177(88)80082-0, PubMed 3417288

Asmussen M, Kaern J, Kjoerstad K, Wright PB, Abeler V (1988)
Primary adenocarcinoma localized to the fallopian tubes: report on 33 cases
Gynecol Oncol, 30 (2), 183-6
DOI 10.1016/0090-8258(88)90022-4, PubMed 3371742

Abeler V, Kjørstad KE, Nesland JM (1988)
Small cell carcinoma of the ovary. A report of six cases
Int J Gynecol Pathol, 7 (4), 315-29
DOI 10.1097/00004347-198812000-00003, PubMed 2852647

Vergote IB, Børmer OP, Abeler VM (1987)
Evaluation of serum CA 125 levels in the monitoring of ovarian cancer
Am J Obstet Gynecol, 157 (1), 88-92
DOI 10.1016/s0002-9378(87)80352-6, PubMed 2440307

Voss R, Reichborn-Kjennerud S, Abeler V, Reith A (1986)
Development of brush cytology for detection of metaplastic and dysplastic nasal mucosa lesions. A preliminary report
Acta Otolaryngol, 101 (3-4), 299-305
DOI 10.3109/00016488609132842, PubMed 3705955

Fosså SD, Abeler V, Marton PF, Lien HH, Høie J (1985)
Sarcoid reaction of hilar and paratracheal lymph nodes in patients treated for testicular cancer
Cancer, 56 (9), 2212-6
DOI 10.1002/1097-0142(19851101)56:9<2212::aid-cncr2820560913>3.0.co;2-n, PubMed 4052967

Vass-Sørensen M, Abeler V, Berle E, Pedersen B, Davy M, Thorsby E, Norrild B (1984)
Prevalence of antibodies to herpes simplex virus and frequency of HLA antigens in patients with preinvasive and invasive cervical cancer
Gynecol Oncol, 18 (3), 349-58
DOI 10.1016/0090-8258(84)90047-7, PubMed 6086470

Fosså SD, Klepp O, Ous S, Lien H, Stenwig JT, Abeler V, Eliassen G, Høst H (1984)
Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapy
Scand J Urol Nephrol, 18 (1), 21-6
DOI 10.3109/00365598409182159, PubMed 6326253

Aalders JG, Abeler V, Kolstad P (1984)
Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients
Gynecol Oncol, 17 (1), 64-74
DOI 10.1016/0090-8258(84)90061-1, PubMed 6693053

Aalders JG, Abeler V, Kolstad P (1984)
Stage IV endometrial carcinoma: a clinical and histopathological study of 83 patients
Gynecol Oncol, 17 (1), 75-84
DOI 10.1016/0090-8258(84)90062-3, PubMed 6693054

Klepp O, Fosså SD, Ous S, Lien H, Stenwig JT, Abeler V, Eliassen G, Høst H (1984)
Multi-modality treatment of advanced malignant germ cell tumours in males. I. Experience with cis-platinum-based combination chemotherapy
Scand J Urol Nephrol, 18 (1), 13-9
DOI 10.3109/00365598409182158, PubMed 6201998

Aalders JG, Abeler V, Kolstad P (1984)
Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients
Gynecol Oncol, 17 (1), 85-103
DOI 10.1016/0090-8258(84)90063-5, PubMed 6693055

Onsrud M, Aalders J, Abeler V, Taylor P (1982)
Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment
Gynecol Oncol, 13 (1), 76-86
DOI 10.1016/0090-8258(82)90011-7, PubMed 7060995

Iversen T, Abeler V, Kolstad P (1981)
Squamous cell carcinoma in situ of the vulva. A clinical and histopathological study
Gynecol Oncol, 11 (2), 224-9
DOI 10.1016/s0090-8258(81)80013-3, PubMed 7215958

Iversen T, Abeler V, Aalders J (1981)
Individualized treatment of stage I carcinoma of the vulva
Obstet Gynecol, 57 (1), 85-9
PubMed 7454180

Aalders J, Abeler V, Kolstad P, Onsrud M (1980)
Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients
Obstet Gynecol, 56 (4), 419-27
PubMed 6999399

Iversen T, Abeler V, Kjørstad KE (1979)
Factors influencing the treatment of patients with stage Ia carcinoma of the cervix
Br J Obstet Gynaecol, 86 (8), 593-7
DOI 10.1111/j.1471-0528.1979.tb10819.x, PubMed 497128

Abeler V (1979)
Sarcoidosis of the cardiac conducting system
Am Heart J, 97 (6), 701-7
DOI 10.1016/0002-8703(79)90004-8, PubMed 433747

Review articles

Kraggerud SM, Hoei-Hansen CE, Alagaratnam S, Skotheim RI, Abeler VM, Rajpert-De Meyts E, Lothe RA (2013)
Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis
Endocr Rev, 34 (3), 339-76
DOI 10.1210/er.2012-1045, PubMed 23575763

Tropé CG, Abeler VM, Kristensen GB (2012)
Diagnosis and treatment of sarcoma of the uterus. A review
Acta Oncol, 51 (6), 694-705
DOI 10.3109/0284186X.2012.689111, PubMed 22793037

Tropé C, Davidson B, Paulsen T, Abeler VM, Kaern J (2009)
Diagnosis and treatment of borderline ovarian neoplasms "the state of the art"
Eur J Gynaecol Oncol, 30 (5), 471-82
PubMed 19899396

Davidson B, Abeler VM (2005)
Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature
Diagn Cytopathol, 32 (5), 307-9
DOI 10.1002/dc.20245, PubMed 15830366

Tropé C, Scheistrøen M, Aas M, Abeler V, Lie K, Makar A (2001)
[Surgery and sentinel node examination in early vulvar cancer]
Tidsskr Nor Laegeforen, 121 (23), 2723-7
PubMed 11699381

Tropé CG, Baekelandt M, Bjørge T, Abeler V, Kaern J (2000)
[Borderline tumors of the ovary]
Tidsskr Nor Laegeforen, 120 (23), 2764-70
PubMed 11107921

Tropé CG, Marth C, Scheistrøen M, Abeler VM (1999)
[Endometrial hyperplasia--diagnosis and treatment]
Tidsskr Nor Laegeforen, 119 (14), 2030-4
PubMed 10394278

Abeler V, Kjørstad KE (1990)
Endometrial squamous cell carcinoma: report of three cases and review of the literature
Gynecol Oncol, 36 (3), 321-6
DOI 10.1016/0090-8258(90)90134-7, PubMed 2180795

Other articles

Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E, Pickart H, Wells M (2000)
Endometrioid neoplasia retrogressive terminology - Reply
Am. J. Surg. Pathol., 24 (5), 754-755

Hanigan MH, Frierson HF, Abeler VM, Kaern J, Taylor PT (1999)
Human germ cell tumours: expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin
Br J Cancer, 81 (1), 75-9
DOI 10.1038/sj.bjc.6690653, PubMed 10487615

Abeler VM, Danielsen HE (1999)
[Telepathology in Norway]
Tidsskr Nor Laegeforen, 119 (9), 1335
PubMed 10327860

Abeler V, Nesland JM (1989)
Alveolar soft-part sarcoma in the uterine cervix
Arch Pathol Lab Med, 113 (10), 1179-83
PubMed 2802951

Abeler V, Kjørstad KE, Langholm R, Marton PF (1983)
Granulocytic sarcoma (chloroma) of the uterine cervix: report of two cases
Int J Gynecol Pathol, 2 (1), 88-92
DOI 10.1097/00004347-198301000-00008, PubMed 6192105

Theses

Abeler VM (1991)
Endometrial carcinoma in Norway: morphology and prognosis
The Norwegian Cancer Society, [Oslo], 1 b. (flere pag.)
BIBSYS 91096209x, ISBN 82-90187-76-9

Page visits: 12056